Meperidine Hydrochloride Injection Market

This product is a powerful analgesic, suitable for all kinds of severe pain, such as traumatic pain, postoperative pain, pre-anaesthesia medication, or local anesthesia and intravenous inhalation combined anesthesia medication.

Meperidine Hydrochloride Injection Market contains market size and forecasts of Meperidine Hydrochloride Injection in global, including the following market information:

Global Meperidine Hydrochloride Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Meperidine Hydrochloride Injection Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Meperidine Hydrochloride Injection companies in 2021 (%)

The global Meperidine Hydrochloride Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

25mg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Meperidine Hydrochloride Injection include Pfizer, Hikma, ICU Medical, Sinopharm, Northeast Pharm and Yichang Humanwell Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Meperidine Hydrochloride Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Meperidine Hydrochloride Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meperidine Hydrochloride Injection Market Segment Percentages, by Type, 2021 (%)

• 25mg/ml
• 50mg/ml
• 75mg/ml
• 100mg/ml

Global Meperidine Hydrochloride Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meperidine Hydrochloride Injection Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinics
• Recovery Center

Global Meperidine Hydrochloride Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Meperidine Hydrochloride Injection Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Meperidine Hydrochloride Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Meperidine Hydrochloride Injection revenues share in global market, 2021 (%)
• Key companies Meperidine Hydrochloride Injection sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Meperidine Hydrochloride Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Hikma
• ICU Medical
• Sinopharm
• Northeast Pharm
• Yichang Humanwell Pharmaceutical